go to contents

Life Sciences Directory

Results

ProFem GmbH

Based on a highly innovative therapeutic concept ProFem develops new medicines for gynecological diseases which are characterized by a hitherto unmet medical need and high market potential. ProFem’s activities are currently focused on infectious diseases of the female lower genitourinary tract associated with the growth of biofilms.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

VelaLabs GmbH

VelaLabs services as a GLP and GMP certified and G(C)LP compliant contract laboratory cover analytical services for Biologics (ATMPs, Biopharmaceuticals, Originator products, Biosimilar Candidates, Biosimilars, Blood and blood components, Vaccines), Chemicals and Excipients from early stages of product development (non-clinical, clinical) until market release testing for Pharma and Biotech companies as well as storage facilities enabling long term stability studies.
 

Organization type
service provider
Region
Vienna
Cluster
LISAvienna
Human.technology Styria
Focus
non-specific applications
human health
Offer
contract research / clinical research
accredited laboratory

Boehringer Ingelheim RCV GmbH

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
industrial processing

Genspeed Biotech GmbH

GENSPEED Biotech GmbH was founded in October 2016 as a spin-off of Greiner Bio-One. We develop, produce and distribute rapid tests based on the IVD-CE certified GENSPEED® technology. With a novel combination of microfluidics, miniaturized optical detection and automation, GENSPEED® allows for the first time to detect a multiple of parameters simultaneously and with high sensitivity at the point of care (POC) in just a few minutes.

Organization type
RDM biotech/pharma
Region
Upper Austria
Focus
human health

Allcyte GmbH

Allcyte is a pioneer in the field of functional precision oncology. The company provides actionable data on the activity of drug candidates directly in live tissue samples of human cancer patients to support strategic R

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Focus
other

DIPHA GmbH

Technology transfer, pharmaceutical development for solid dosage forms (tablet, granulates, a.o.) for clinical studies, liquids and creams. Study development and monitoring (Phase I-II), CRO biomarker development for inflammatory and autoimmun diseases, product management for pharmacies, licensing and marketing

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health / animal health
Offer
contract research / clinical research
other
contract manufacturing
Focus
other

OncoOne Research

Please visit our website: www.oncoone.com

Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health

Pfizer Manufacturing Austria GmbH

Pfizer Manufacturing Austria is Pfizer’s production site at Orth an der Donau. The plant meets global demand for vaccines to protect against tickborne encephalitis and meningitis caused by serogroup C meningococci.

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
ecoplus
Focus
industrial processing

Proxygen GmbH

Proxygen harnesses the cellular protein quality control system to develop therapies against cancer and other life-threatening diseases. We are focused on particular small molecules called “molecular glue degraders” which mediate recruitment of a disease-causing protein to a ubiquitin ligase where it is ubiquitinated and directed to the proteasome for degradation. Hence, instead of merely blocking the function of harmful proteins, molecular glue degraders enable their complete and selective elimi

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

3D Spine Matrix Biotechnologie GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health
Focus
other

APEIRON Biologics AG

APEIRON Biologics AG at a glance: APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. APEIRON Biologics´ projects and technologies are based on a strong patent portfolio and partnerships with leading pharmaceutical companies and academic institutions.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Hookipa Biotech AG

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that reprograms the body’s immune system.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

a:head bio AG

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Evercyte GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
non-specific applications

Syconium Lactic Acid GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
industrial processing

Chorus GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
ecoplus
Focus
non-specific applications

Origimm Biotechnology GmbH, a Sanofi company

Origimm (‘Origins of immunity’) is a biotech company that specializes in the discovery of antigens and dermatological drug targets. The company uses its proprietary technology that employs reverse functional screening to discover and develop breakthrough therapies for the prevention and treatment of skin microbiome-associated diseases such as acne vulgaris and other microbiome-associated infections.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Accanis Biotech F

What if we could give the body instructions to produce its own drugs? This would be nothing less than a new era in drug therapy and is exactly what messenger RNA (mRNA) could achieve. At ACCANIS, we develop innovative therapeutics for the treatment of common, localized diseases using mRNA. Each cell in your body uses mRNA to translate genetic information into proteins. ACCANIS´ innovative technology takes advantage of this natural mechanism in order to enable effective, on-demand therapeutics.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Solgate GmbH

Solgate is a new research-driven biopharmaceutical startup that develops drugs targeting solute carrier (SLC) proteins, the largest family of membrane transporters. By modulating the function of the “gates” to cellular metabolism, Solgate aims to address unmet medical needs in neurological diseases, in metabolic disorders and in cancer. Solgate is located in the newly established IST Park, a space housing a growing community of technology startups and biotech companies, adjacent to IST Austria.

Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health
Focus
other

SELO Medical GmbH

Organization type
RDM biotech/pharma
Region
Salzburg
Filter
Reset filter